Document is current
Any future updates will be listed below
-
Authors
Springfeld, Christoph
Ferrone, Cristina R.
Katz, Matthew H. G. http://orcid.org/0000-0003-3870-6968
Philip, Philip A.
Hong, Theodore S.
Hackert, Thilo
Büchler, Markus W.
Neoptolemos, John http://orcid.org/0000-0002-6201-7399
- License Information
-
More Information
Article History
Accepted: 21 February 2023
First Online: 17 March 2023
Competing interests
: C.S. has acted as an adviser to AstraZeneca, Bayer, Eisai, lncyte, MSD, Roche and Servier. P.A.P. has received honoraria and/or acted as a consultant to AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi, Guardant, Incyte, Ipsem, Merck, Servier, Tempus and Trisalus, has received research support from Caris, Karyopharm, Novocure and Rafael, and is a member of data safety monitoring boards for Cyclacel, Erytech and Oncolytics. T.H. has acted as an adviser and/or consultant to Boston Scientific, GSK, lnviata, the Lustgarten Foundation, Merck, Novocure and Pan Ther Therapeutics, and has received research funding from AstraZeneca, BMS, GSK, lntraOp, lpsen and Taiho. The other authors declare no competing interests.
